What Monitoring the Air in Hundreds of British Classrooms Found

Since 2022 a citizen science project called SAMHE, Schools’ Air quality Monitoring for Health and Education, has put low cost air quality monitors into classrooms across the UK, with pupils and teachers reading the data themselves as part of the project rather than researchers simply collecting it from a distance. Two papers published from that dataset over the past eighteen months, one covering fine particulate matter across 490 schools and the other covering ventilation across 322, give the clearest national picture yet of what is actually in the air where children spend a large share of their day. Neither points mainly to what happens minute to minute in a classroom. Both point to things a school has far less control over, where the building sits and how well it is funded.

The Outdoor Air Problem a Window Cannot Fix

The larger of the two studies, led by Alice Handy and colleagues and published in Science of the Total Environment in 2025, analysed fine particulate matter, PM2.5, readings from 490 schools across the UK monitored through the 2023 to 2024 academic year. Its central finding is that indoor PM2.5 concentrations in schools closely track outdoor ambient levels, with outdoor air acting as the dominant source of the particulate matter measured inside. Short, episodic spikes in outdoor pollution, the kind of day when outdoor air quality is noticeably worse than usual, contributed a disproportionate share of a school’s total exposure across the year, rather than exposure building up steadily and evenly.

That finding matters because it complicates the usual advice about improving indoor air, opening windows, upgrading ventilation systems, running air cleaners. All of those measures help with pollutants generated inside a building, but a school sitting near a busy road or in an area with generally poorer air quality is drawing much of its indoor pollution problem in from outside, whatever it does internally. Fixing that runs into questions of where schools are built and how local air quality is managed, questions that sit well outside any individual school’s control.

Ventilation, Deprivation and a Threshold Most Schools Meet, Except in the Cold

The second study, by Samuel Wood, Alice Handy, Katherine Roberts and Henry Burridge, published in Developments in the Built Environment in October 2024, used carbon dioxide readings as a proxy for ventilation rate, working from around 9,406 school days of data collected across 322 schools during autumn 2023, with 190 schools included in the final analysis. The overall mean ventilation rate came out at 5.3 litres per second per person, though that figure moved substantially with the weather, rising to 6.8 in warmer conditions and falling to 3.8 when it turned cold. Daily mean CO2 levels stayed below the government’s Building Bulletin 101 guidance threshold of 1,500 parts per million in the majority of schools, and nearly half never exceeded it at all across the whole study period. The exceptions clustered predictably around temperature: once outdoor conditions dropped to around 5 degrees Celsius, the share of school days exceeding the threshold rose to roughly one in five, consistent with windows being kept shut against the cold rather than for air quality reasons.

What stood out once outdoor temperature was accounted for was who was left with the higher readings. State funded schools showed higher CO2 concentrations than private schools, and schools in more deprived areas showed higher levels than those in less deprived ones. Secondary schools ran higher than primary schools too, though that gap narrowed considerably once the researchers adjusted for the fact that older pupils simply produce more CO2 per body than younger ones. Schools operating above their nominal pupil capacity consistently showed higher concentrations than those within it. None of these differences point to how conscientiously staff were managing their classrooms. They point to building age, funding and occupancy, factors that track a school’s resources rather than its day to day practices.

A National Baseline That Did Not Exist Before

What makes both studies notable is less any single figure than the dataset behind them. Most previous UK research on classroom air quality covered a handful of schools at most, monitored for a short period. SAMHE is led by the Stockholm Environment Institute’s York centre at the University of York, working with Imperial College London, the University of Cambridge, the University of Surrey and the University of Leeds, funded by the Department for Education and the Engineering and Physical Sciences Research Council. It is running from 2022 to 2029 and has already produced two papers covering hundreds of schools simultaneously across a full academic year, drawing on the same shared monitoring network and overlapping research teams. Since those papers were published, the government has itself updated its practical guidance for schools, issuing new advice on ventilation and air quality in England’s education and childcare settings in February 2026 that keeps the same 1,500 parts per million daily mean ceiling the SAMHE studies measured against, while adding a lower 800 parts per million marker below which ventilation is described as good.

Taken together, the two studies reframe what improving classroom air quality actually requires. Better ventilation habits and cleaner outdoor air both matter, and the evidence linking CO2 levels to pupil concentration and PM2.5 exposure to respiratory health is well established elsewhere. But the specific pattern SAMHE has found, outdoor pollution driving indoor exposure regardless of what a school does internally, and CO2 levels tracking a school’s funding and location as much as its ventilation practices, means the fix is not simply a matter of better habits inside the classroom. It runs into decisions about where schools are sited, how they are funded and how crowded they are allowed to become, questions that go well beyond what any single teacher or head can control.

Sources: Science of the Total Environment (Handy et al, 2025); Developments in the Built Environment (Wood, Handy, Roberts and Burridge, 2024); Stockholm Environment Institute (SAMHE project).

Author

Leave A Comment

Graham Combe

Strategic Consultant,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Graham Combe is an experienced strategic consultant, relationship builder, and entrepreneur in the global life sciences sector. He holds a BSc (Hons) in Chemistry from University College London (UCL) and spent over a decade with Nature, where he pioneered key initiatives such as Nature’s BioPharma Dealmakers and Nature’s SciCafe.

In May 2011, he founded Biosell UK, a consulting and event management firm that collaborates with global life science publishers, event organizations, and marketing partners. Beyond BioSell, Combe is the founder or co-founder of several prominent networking and thought-leadership platforms, including #BiotechBuddies, #coffeebuddies, the #AgileLeaders Forum, and the Creative Disruption Forum—the latter three events co-hosted with his business partner, Professor Tony Sedgwick.

Specializing in the early-to-mid stages of drug development (from pre-clinical research through Phase 3 and clinical proof-of-concept), Graham focuses on facilitating forums to promote peer-to-peer discussion, strategic growth, investment and meaningful connections between biotech innovators, investors, and industry service providers.

Apply for a complimentary Conference Day VIP Pass

Apply for a complimentary Conference Day VIP Pass

Complimentary Conference Day VIP Passes are reserved for senior leaders and decision-makers with influence over purchasing, commissioning, investment or technology advancements and adoption across UK life sciences.

A Conference Day VIP Pass includes:

  • Complimentary access-all-areas to the Launch Day Conference
  • Access to the dedicated VIP green room alongside Conference speakers
  • Access to all general keynote, panel and programme sessions
  • Curated networking opportunities
  • Opportunities to meet conference speakers and other approved VIP attendees

The VIP Pass applies to the Launch Day Conference only. It does not include admission to the Life Sciences Week Gala Dinner or other separately ticketed events.

Applications are reviewed individually and submitting this form does not guarantee a complimentary pass. To maintain a balanced, high-quality audience, we may limit the number of VIP Passes issued to any one organisation.

    First Name *

    Last Name *

    Work Email Address *

    Telephone Number *

    Job Title *

    Organisation *

    LinkedIn

    Organisation Information

    Which best describes your organisation? *


    If other, please specify

    Which best describes your level of seniority? *

    If other, please specify

    Which areas are you responsible for or directly involved in? *

    If other, please specify

    What best describes your role in purchasing, investment, commissioning or adoption decisions? *

    Attendance Information

    Briefly, what is the number one thing you are hoping to get out of attending Life Sciences Week 2026? *

    Final Confirmation

    Is your role primarily focused on selling products or services, consultancy, account management or business development? *

    Please Confirm *

    I understand that VIP applications are subject to review and approval.
    I understand that the complimentary VIP Pass covers the Life Sciences Week Launch Day Conference only and does not include the Gala Dinner Awards or other separately ticketed events.
    The information supplied in this application is accurate.

    Shabna Raja

    Advisory Partner,
    Life Sciences Week
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Shabna Raja is a senior leader in enterprise transformation within Life Sciences, with over 20 years’ experience spanning pharma, consumer health and large-scale digital programmes.

    She specialises in bridging strategy and execution – helping organisations translate AI, data and digital innovation into tangible business outcomes. Her work focuses on complex transformation
    initiatives across commercial, data and operating model domains within regulated environments.

    Shabna spent seven years at GSK, where she played a key role in transformation programmes, including as part of the Consumer Health joint venture with Pfizer — one of the most significant integrations in the sector. This experience provided her with deep expertise in  organisational change, integration and operating model evolution at global scale.

    More recently, she has spent over three years working closely with Haleon through a strategic
    services partnership, leading enterprise client engagement and managing a multi-million-pound account while supporting transformation across a newly independent global organisation.

    Her experience spans the end-to-end life sciences value chain, including R&D, commercial, supply chain and patient engagement, giving her a holistic perspective on how technology and transformation can unlock value across the industry.

    Amjad Khan

    Executive Partner,
    Life Sciences Week
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Amjad Khan is a UK-based entrepreneur, AI strategist, and senior technology leader with over 15 years of experience at Pfizer, where he held multiple leadership roles across digital strategy and transformation. As Global Digital Client Partner, he was responsible for digital strategy and execution across Global Business Units covering Vaccines, Hospital, and Medical Affairs. Most notably, he led the commercial launch for the Covid franchise transforming and accelerating the model for how new medicines are brought to market.

    Following his tenure at Pfizer, Amjad channelled his expertise into building at the frontier of AI. His work spans AI leadership, stakeholder engagement, and agile delivery helping organisations adopt and scale emerging  technologies to drive meaningful outcomes.

    Dr. Richard Fallon | Business Consultant | WM Life Sciences

    Dr. Richard Fallon

    Co Founder, Life Sciences Week 
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Dr Richard Fallon is an entrepreneur and ecosystem builder who connects industry leaders, investors and public-sector stakeholders to accelerate collaboration and commercial growth.

    As the Founder of the Technology Supply Chain and co-founder of the Innovation Awards, he has spent more than two decades convening influential networks that help emerging businesses find capital, strategic partners and new routes to market.

    Richard’s work spans leadership and consultancy across major organisations, alongside building membership and partnership platforms that bring universities, industry and investors into the same room – and turn conversations into practical outcomes.

    With his focus on life sciences, Richard supports organisations and people driving breakthroughs in healthcare, biotechnology, medical technology and advanced research. He is passionate about creating the conditions for transformative ideas to move from concept to real-world impact – by connecting innovators with the funding, expertise and opportunities they need to scale.

    Through Life Sciences Week, Richard is championing the UK’s world-class life sciences community and helping position it at the forefront of innovation, investment and patient outcomes.

    Amy Deakin | Chief of Staff | WM Life Sciences

    Amy Deakin

    Event Managing Director,
    Life Sciences Week
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Amy Deakin is a Birmingham-based leader specialising in building partnerships and fostering innovation in the life sciences sector. With a degree in Sport and Exercise Science, Amy brings a grounded understanding of human health and performance to her work and a strong interest in the developments shaping healthcare today.

    Amy is Managing Director of Life Sciences Week, part of the One Thousand Trades Group, and also serves as Director of One Thousand Trades Events. In these roles, she convenes researchers, clinicians and industry leaders to strengthen collaboration, unlock new partnerships and help accelerate real-world innovation across the life sciences ecosystem.

    Her career spans both commercial and third-sector environments. She began in automotive design, delivering projects for Volkswagen, McLaren, Bentley and Jaguar Land Rover, before moving into the third sector with Acorns Children’s Hospice. She later joined Western Union, working as a Partnerships Manager for international payments

    An avid netballer, Amy is a committed advocate for health and wellbeing – bringing energy, clarity and connection to everything she builds, and actively involved as a participant in health related research studies.

      Award Category Voting

      Here's a list of all categories you can vote for. Simply click each category to cast your vote. Voting in each category is not mandatory, so please feel free to click just the category that interests you.

      Day you've not voted in, will be denoted with an ❌

      If you're having issues submitting the form, please ensure all the category boxes are closed and try again.

      Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

      No VoteProf. Alex RichterBlack Space TechnologyAston Vision Sciences

      Celebrating an emerging leader making significant contributions to the field through research, innovation, or leadership.

      Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

      No VoteShashank Chaganty – VichagLeah Vanono - PBS InnovationsKloe Avon- KZ Organics

      Honouring successful cross-sector partnerships driving advancements in life sciences, from academia to industry.

      No VoteProf Liam Grover- WMHTIAJudith Stewart- Health Innovation West MidlandsAdam McGuinness - Plug and Play

      Awarding an individual or organisation for exceptional long-term impact on the industry.

      No VoteDavid KidneyMedilink MidlandsUniversity of Birmingham

      Highlighting innovations in treatments, diagnostics, or healthcare delivery that have significantly improved patient outcomes.

      No VoteJean-Louis Duprey - Linear DiagnosticsSian Dunning - MD-TECKarim Vissangy - HoloMedix

      Your Details